ATE58839T1 - Zusammensetzungen und verfahren zur wundheilung. - Google Patents

Zusammensetzungen und verfahren zur wundheilung.

Info

Publication number
ATE58839T1
ATE58839T1 AT85301127T AT85301127T ATE58839T1 AT E58839 T1 ATE58839 T1 AT E58839T1 AT 85301127 T AT85301127 T AT 85301127T AT 85301127 T AT85301127 T AT 85301127T AT E58839 T1 ATE58839 T1 AT E58839T1
Authority
AT
Austria
Prior art keywords
collagen
glycosaminoglycan
suspension
present
compositions
Prior art date
Application number
AT85301127T
Other languages
English (en)
Inventor
Dov Michaeli
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE58839T1 publication Critical patent/ATE58839T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT85301127T 1984-02-24 1985-02-20 Zusammensetzungen und verfahren zur wundheilung. ATE58839T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/583,159 US4745098A (en) 1984-02-24 1984-02-24 Compositions and method for improving wound healing
EP85301127A EP0154447B1 (de) 1984-02-24 1985-02-20 Zusammensetzungen und Verfahren zur Wundheilung

Publications (1)

Publication Number Publication Date
ATE58839T1 true ATE58839T1 (de) 1990-12-15

Family

ID=24331918

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85301127T ATE58839T1 (de) 1984-02-24 1985-02-20 Zusammensetzungen und verfahren zur wundheilung.

Country Status (6)

Country Link
US (1) US4745098A (de)
EP (1) EP0154447B1 (de)
JP (1) JPH0751512B2 (de)
AT (1) ATE58839T1 (de)
CA (1) CA1258630A (de)
DE (1) DE3580769D1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
AR243204A1 (es) * 1986-11-21 1993-07-30 Ajorca Sa Un metodo para la depolimerizacion quimica de polisacaridos.
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
JPS63229068A (ja) * 1987-03-17 1988-09-22 新技術事業団 電気刺激創傷治療装置
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
WO1989000043A1 (en) * 1987-07-08 1989-01-12 Martin Kludas Ophthalmic agent and related compositions and method for treatment of the cornea
US5036056A (en) * 1987-07-08 1991-07-30 Martin Kludas Methods for treating damaged corneal, uterine, or cartilage tissue
US5055298A (en) * 1987-12-01 1991-10-08 Chemisches Laboratorium Dr. Kurt Richter Gmbh Cosmetic composition comprising an extracellular connective tissue matrix
US4945086A (en) * 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5219576A (en) * 1988-06-30 1993-06-15 Collagen Corporation Collagen wound healing matrices and process for their production
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
JP2807741B2 (ja) * 1988-12-22 1998-10-08 コレチカ リポソームの安定化方法、安定化リポソーム組成物、ならびにそれを含む医薬組成物および化粧料組成物
EP0421508B1 (de) * 1989-10-04 1993-12-15 Akzo Nobel N.V. Sulfatierte Glykosaminoglykuronane mit antithrombotischer Wirkung.
WO1991006303A1 (en) * 1989-10-27 1991-05-16 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
CA2081340A1 (en) * 1990-04-26 1991-10-27 R. Martin Emanuele Composition and method for topical treatment of damaged or diseased tissue
US5500409A (en) * 1990-10-01 1996-03-19 Thomas Jefferson University Method for inhibiting collagen synthesis by keloid fibroblasts
SE9101155D0 (sv) * 1991-04-18 1991-04-18 Kabi Pharmacia Ab Novel heparin derivatives
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
US5670169A (en) * 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
DK2111876T3 (da) 1995-12-18 2011-12-12 Angiodevice Internat Gmbh Tværbundne polymerpræparater og fremgangsmåder til anvendelse deraf
US7883693B2 (en) 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
US6833408B2 (en) 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
US5668119A (en) * 1996-02-22 1997-09-16 Medenica; Rajko D. Topical pharmaceutical containing heparin and method of treatment
US6451326B2 (en) 1996-05-02 2002-09-17 Burt D. Ensley Cosmetic compositions
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
AU2002342613A1 (en) * 2001-05-09 2002-11-25 Geron Corporation Treatment for wounds
AU2003252694A1 (en) * 2002-07-26 2004-02-16 Mikasa Seiyaku Co., Ltd. External preparation
WO2006030965A1 (en) 2004-09-15 2006-03-23 Seikagaku Corporation Photoreactive polysaccharide, photocrosslinked polysaccharide products, the method of making them and medical materials therefrom
CA2581093C (en) 2004-09-17 2014-11-18 Angiotech Biomaterials Corporation Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
JP5031370B2 (ja) * 2004-09-17 2012-09-19 セルジェンテック株式会社 外用皮膚潰瘍治療剤
ES2604559T3 (es) 2011-04-19 2017-03-07 Bioiberica, S.A. Producto de cartílago
US9782457B2 (en) * 2011-10-07 2017-10-10 Tissue Repair Company Flowable formulations for tissue repair and regeneration
US9393278B2 (en) 2013-06-26 2016-07-19 Han Sheng Biotech Co., Ltd. Method for wound healing
CN110038115A (zh) * 2019-04-18 2019-07-23 北京和生康医疗科技有限公司 矿物质型碱性组合物及其制备方法与用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6652M (de) * 1966-12-28 1969-01-27
US4060081A (en) * 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
GB1515963A (en) * 1975-07-15 1978-06-28 Massachusetts Inst Technology Crosslinked collagen-mucopolysaccharide composite materials
FR2362632A1 (fr) * 1976-08-23 1978-03-24 Moreau Monique Nouvelles preparations pour le traitement des manifestations corporelles inesthetiques et procede de traitement
JPS6019725B2 (ja) * 1977-10-04 1985-05-17 ポ−ラ化成工業株式会社 皮膚化粧料
US4350629A (en) * 1981-07-29 1982-09-21 Massachusetts Institute Of Technology Procedures for preparing composite materials from collagen and glycosaminoglycan
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
FR2517315B1 (fr) * 1981-11-30 1985-12-20 Tech Cuir Centre Procede de preparation de formes nouvelles de collagene, natif ou dereticule, a structure helicoidale preservee, associees a des mucopolysaccharides et leurs applications notamment dans les domaines cosmetologiques, pharmaceutiques, analytiques et autres
US4448718A (en) * 1983-09-13 1984-05-15 Massachusetts Institute Of Technology Method for the preparation of collagen-glycosaminoglycan composite materials

Also Published As

Publication number Publication date
EP0154447A2 (de) 1985-09-11
CA1258630A (en) 1989-08-22
JPS60222425A (ja) 1985-11-07
EP0154447B1 (de) 1990-12-05
DE3580769D1 (de) 1991-01-17
EP0154447A3 (en) 1987-08-12
JPH0751512B2 (ja) 1995-06-05
US4745098A (en) 1988-05-17

Similar Documents

Publication Publication Date Title
ATE58839T1 (de) Zusammensetzungen und verfahren zur wundheilung.
ATE113636T1 (de) Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
NZ233451A (en) Production of vascular endothelial growth factor and dna encoding same
ATE87452T1 (de) Prothese fuer meniscus.
ES2148504T3 (es) Acido hialuronico sulfatado en el que el numero de grupos sulfato por unidad repetitiva varia entre 0,5 y menos de 2.
EP0402740A3 (de) Reflektor für eine Leuchte und Verfahren zum Bestimmen der Form eines Reflektors
ES2130268T3 (es) Preparados de acido hialuronico de bajo peso molecular, para estimulacion de formacion de huesos.
DE60013857D1 (de) Gemisch und methode zur verbesserung der wundheilung
IT8820412A0 (it) Sulfoamino derivati di condroitinsolfati, del dermatan solfato e dell'acido ialuronico e loro proprieta' farmacologiche.
ES8608889A1 (es) Procedimiento para la obtencion de un deposito de antibioti-co resorbible
DE69523585D1 (de) Wundheilmittel
NZ333925A (en) Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
NZ290218A (en) Composition to reduce adhesion in wound healing
KR930000120A (ko) 간실질세포 증식제
DK0462194T3 (da) Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger
ES2024641B3 (es) Preservativo.
ES2012563A6 (es) Un procedimiento pra la extraccion de sulfato de heparano de organos y tejidos de animales.
GB9616896D0 (en) Pharmaceutical compositions
ATE227995T1 (de) Verwendung von pseudopterosin zur förderung der wundheilung
EP0373540A3 (de) Verfahren zur Reinigung des Fibroblast-Wachstumsfaktor-Proteins
ES8207191A2 (es) Procedimiento para la preparacion de nuevos poli(h-)sulfatosde rutina y sales de los mismos
YU47599B (sh) Postupak za prečišćavanje vodenog n-metilmorfolin-n-oksidnog rastvora
ES8507000A1 (es) Metodo para la preparacion y purificacion de concentrados de factor viii antihemofilia de la sangre
ES456196A1 (es) Un metodo para la preparacion de heparina de elevada activi-dad especifica.
IT8324293A0 (it) Uso dell'acetilcisteina per ridurre l'incremento della proliferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time